Alfresa Holdings Corporation
2784・Prime Market・Wholesale Trade
Alfresa Holdings Corporation2784
Alfresa Holdings Corporation2784
Reference Indicators
Market Cap
4,471¥100M
P/E (Forecast)
—
P/B
0.8x
Dividend Yield (Forecast)
3.04%
ROE
8.4%
EV/EBITDA
5.5x
Financial Summary
Unit: ¥M
| Item | 2022Mar 2022 | 2023Mar 2023 | 2024Mar 2024 | 2025Mar 2025 | 2026Mar 2026 |
|---|---|---|---|---|---|
Net Sales | 2,585,643 | 2,696,069 | 2,858,500 | 2,961,051 | 3,104,064 |
Cost of Sales | 2,398,174 | 2,503,983 | 2,652,128 | 2,747,123 | 2,886,183 |
Gross Profit | 187,468 | 192,085 | 206,371 | 213,927 | 217,880 |
SG&A Expenses | 158,377 | 161,937 | 167,910 | 175,846 | 181,716 |
Operating Income | 29,091 | 30,148 | 38,460 | 38,080 | 36,164 |
Non-operating Income | 4,057 | 3,122 | 3,030 | 3,347 | 3,687 |
Non-operating Expenses | 573 | 440 | 1,494 | 942 | 1,217 |
Ordinary Income | 32,576 | 32,831 | 39,997 | 40,485 | 38,634 |
Extraordinary Income | 19,050 | 9,411 | 5,863 | 6,906 | 25,343 |
Extraordinary Losses | 3,446 | 3,650 | 2,065 | 8,032 | 1,970 |
Pre-tax Income | 48,180 | 38,591 | 43,795 | 39,359 | 62,007 |
Income Taxes | 15,977 | 12,802 | 14,221 | 11,923 | 20,175 |
Net Income | 32,182 | 25,786 | 29,558 | 27,389 | 41,746 |
EBITDA | 41,915 | 43,450 | 51,974 | 53,003 | 51,212 |
Gross Margin | 7.3% | 7.1% | 7.2% | 7.2% | 7.0% |
Operating Margin | 1.1% | 1.1% | 1.3% | 1.3% | 1.2% |
ROA | 2.5% | 1.9% | 2.0% | 1.9% | 2.8% |
ROE | 6.7% | 5.4% | 6.1% | 5.7% | 8.4% |
Segment Performance
Unit: ¥M
2026
| Segment | Net Sales | Operating Income | Operating Margin |
|---|---|---|---|
| 医療用医薬品等卸売事業 | 2,763,082 | 33,297 | 1.2% |
| セルフメディケーション卸売事業 | 266,626 | 3,012 | 1.1% |
| 医薬品等製造事業 | 37,181 | 1,203 | 3.2% |
| 調剤薬局等事業 | 37,174 | 499 | 1.3% |
| その他 | 0 | 0 | 0.0% |